291 GENES FOUND

? »

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CD80CD80 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD86CD86 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CHD1Chromodomain helicase DNA binding protein 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
CHRM1Cholinergic receptor, muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRM3Cholinergic receptor, muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Transporters
Mixed
CKBCreatine kinase, brainCancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
CKMCreatine kinase, muscleCandidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
CLCN2Chloride channel, voltage-sensitive 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
COMTCatechol-O-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CPS1Carbamoyl-phosphate synthase 1, mitochondrialDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Group enriched
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CPT2Carnitine palmitoyltransferase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Expressed in all
CSF3RColony stimulating factor 3 receptor (granulocyte)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CYP11B1Cytochrome P450, family 11, subfamily B, polypeptide 1Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted intracellular proteins
Tissue enriched
CYP17A1Cytochrome P450, family 17, subfamily A, polypeptide 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
CYP19A1Cytochrome P450, family 19, subfamily A, polypeptide 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
CYP51A1Cytochrome P450, family 51, subfamily A, polypeptide 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
DBHDopamine beta-hydroxylase (dopamine beta-monooxygenase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
DDCDopa decarboxylase (aromatic L-amino acid decarboxylase)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
DHODHDihydroorotate dehydrogenase (quinone)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
DNMT1DNA (cytosine-5-)-methyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transcription factors
Expressed in all
DPEP1Dipeptidase 1 (renal)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
DPP4Dipeptidyl-peptidase 4CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
DRD5Dopamine receptor D5Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
EDNRAEndothelin receptor type AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
ELANEElastase, neutrophil expressedCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
ERBB2V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
ESR1Estrogen receptor 1Cancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Group enriched
F2Coagulation factor II (thrombin)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
F8Coagulation factor VIII, procoagulant componentCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
FASNFatty acid synthaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
FCER1AFc fragment of IgE, high affinity I, receptor for; alpha polypeptideFDA approved drug targets
Predicted membrane proteins
Mixed
FCER1GFc fragment of IgE, high affinity I, receptor for; gamma polypeptideFDA approved drug targets
Predicted membrane proteins
Expressed in all
FCGR2AFc fragment of IgG, low affinity IIa, receptor (CD32)CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
FCGR2BFc fragment of IgG, low affinity IIb, receptor (CD32)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FDPSFarnesyl diphosphate synthaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FGF1Fibroblast growth factor 1 (acidic)Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Group enriched
FGF2Fibroblast growth factor 2 (basic)Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Mixed
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FLT4Fms-related tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FN1Fibronectin 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced

« prev | Page of 6 | next »